← All peptidesBlends
HGH Frag 176-191 + CJC-1295 + Ipamorelin
HGH Fragment 176-191 + CJC-1295 (no DAC) + Ipamorelin
Cutting blend pairing a lipolytic GH fragment with GH secretagogues, studied for fat mobilization without hyperglycemia.
Typical dose
250–500 mcg
Frequency
Fasted / pre-cardio, daily
Half-life
—
Route
subcutaneous
Typical vial sizes
12 mg
Sample reconstitution
12 mg vial · 2 mL bac water · 375 mcg dose
- Draw volume
- 0.063 mL
- Insulin units
- 6 units
- Concentration
- 6.00 mg/mL
- Doses per vial
- 32.0
Research notes
As sold: Fragment 176-191 6mg + CJC-1295 no-DAC 3mg + Ipamorelin 3mg. Fragment carries the fat-loss framing; GHRH+GHS drive GH pulses.
Further reading
- Published research on HGH Frag 176-191 + CJC-1295 + Ipamorelin (PubMed) →
- Clinical trials for HGH Frag 176-191 + CJC-1295 + Ipamorelin (ClinicalTrials.gov) →
Links open live searches on authoritative databases — verify dosing and safety against primary sources.
Research use only.
Information on this page is a reference log compiled from public sources and is not medical advice. Consult a licensed physician before making any decisions about your health.